• How Many Pills of Furmonertinib Should I Take Per Day?

  The standard dosage of furmonertinib is oral administration twice daily, 80 mg each time (specific medication use shall follow the doctor's instru···【Read More】

  Update: 2026-01-30Source: Haiou HealthViews: 76

• Side Effects of Furmonertinib

  Furmonertinib is a third-generation targeted therapy drug targeting epidermal growth factor receptor (EGFR) gene mutations, primarily indicated for th···【Read More】

  Update: 2026-01-30Source: Haiou HealthViews: 83

• Furmonertinib - Package Insert

  Furmonertinib is an oral targeted therapeutic agent indicated for epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer···【Read More】

  Update: 2026-01-30Source: Haiou HealthViews: 83

• What is Taletrectinib?

  Taletrectinib is a second-generation anaplastic lymphoma kinase (ALK) inhibitor, primarily indicated for the treatment of advanced non-small cell lung···【Read More】

  Update: 2026-01-29Source: Haiou HealthViews: 75

• Functions and Indications of Taletrectinib

  Taletrectinib is a targeted therapeutic agent that exerts its effects primarily by inhibiting the overactivation of the MET protein. It is indicated f···【Read More】

  Update: 2026-01-29Source: Haiou HealthViews: 74

• Side Effects of Tarlatamab

  Tarlatamab is a targeted therapeutic drug primarily indicated for the clinical treatment of specific types of cancer. Its common side effects include ···【Read More】

  Update: 2026-01-29Source: Haiou HealthViews: 74

• How Many Capsules of Taletrectinib Should Be Taken Daily?

  Taletrectinib is a medication used for the treatment of specific types of non-small cell lung cancer. The standard recommended dosage is 0.6 grams (eq···【Read More】

  Update: 2026-01-29Source: Haiou HealthViews: 74

• Taletrectinib Package Insert

  Taletrectinib is a targeted therapeutic agent for the treatment of ALK/ROS1 gene fusion-positive non-small cell lung cancer (NSCLC). It inhibits the g···【Read More】

  Update: 2026-01-29Source: Haiou HealthViews: 79

• Administration of Sunvozertinib in Special Populations

  For the administration of Sunvozertinib in special populations, the dosage regimen should be adjusted based on individual conditions, with a key focus···【Read More】

  Update: 2026-01-27Source: Haiou HealthViews: 84

• Important Considerations for Taking Sunvozertinib

  Sunvozertinib is a targeted therapy drug for lung cancer with specific gene mutations. Key considerations for its use include strict adherence to medi···【Read More】

  Update: 2026-01-27Source: Haiou HealthViews: 78

• Side Effects of Sunvozertinib

  Sunvozertinib is a targeted therapy agent indicated for specific gene mutations (e.g., EGFR exon20ins), primarily used in the treatment of non-small c···【Read More】

  Update: 2026-01-27Source: Haiou HealthViews: 82

• Sunvozertinib: Usage and Dosage

  Sunvozertinib is an oral targeted therapy indicated for the treatment of specific subtypes of non-small cell lung cancer (NSCLC), such as those with E···【Read More】

  Update: 2026-01-27Source: Haiou HealthViews: 79

• Package Insert for ​Sunvozertinib

  Sunvozertinib is an oral targeted therapeutic agent for specific gene mutations, whose active ingredient inhibits the abnormal activity of two protein···【Read More】

  Update: 2026-01-27Source: Haiou HealthViews: 81

• Medication in Special Populations: Glumetinib

  Glumetinib, a MET inhibitor indicated for the treatment of patients with specific non-small cell lung cancer, requires dosage adjustments based on the···【Read More】

  Update: 2026-01-26Source: Haiou HealthViews: 77

• Precautions for the Use of Glumetinib

  Glumetinib is an oral targeted therapy agent indicated primarily for the treatment of patients with advanced non-small cell lung cancer (NSCLC) harbor···【Read More】

  Update: 2026-01-26Source: Haiou HealthViews: 80